Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).

HLA class I alleles, in particular HLA-B*57, constitute the most consistent host factor determining outcomes in untreated HCV- and HIV-infection. In this prospective cohort study, we analysed the impact of HLA class I alleles on all-cause mortality in patients with HIV-, HCV- and HIV/HCV- co-infecti...

Full description

Bibliographic Details
Main Authors: Leona Dold, Golo Ahlenstiel, Eva Althausen, Carolin Luda, Carolynne Schwarze-Zander, Christoph Boesecke, Jan-Christian Wasmuth, Jürgen Kurt Rockstroh, Ulrich Spengler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4524598?pdf=render

Internet

http://europepmc.org/articles/PMC4524598?pdf=render

Similar Items